AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,305,000 | +161.5% | 46,468 | +252.9% | 0.06% | +132.1% |
| Q2 2019 | $499,000 | -9.8% | 13,168 | -7.1% | 0.03% | -15.2% |
| Q1 2019 | $553,000 | +98.2% | 14,168 | +100.5% | 0.03% | +153.8% |
| Q3 2018 | $279,000 | -33.1% | 7,068 | -35.3% | 0.01% | -23.5% |
| Q2 2018 | $417,000 | -18.9% | 10,925 | -36.2% | 0.02% | -19.0% |
| Q1 2018 | $514,000 | – | 17,125 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |